论文部分内容阅读
美国食品和药品管理局(FDA)于2011年7月26日发布药物安全警告:服用5-羟色胺能精神病药物(serotonergic psychiatricmedications)的患者应用利奈唑胺(linezolid)可能导致严重的中枢神经系统反应。FDA同时也发布了该类患者应用亚甲蓝有相似风险的安全警告。
US Food and Drug Administration (FDA) released on July 26, 2011 Drug Safety Warning: Applying linezolid to patients taking serotonergic psychiatric medications can cause severe central nervous system reactions. The FDA also issued a safety warning that similar risks apply to methylene blue in these patients.